Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Invested Capital (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Return on Invested Capital for 2 consecutive years, with 0.29% as the latest value for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 13.0% year-over-year to 0.29%; the TTM value through Dec 2025 reached 0.29%, up 13.0%, while the annual FY2025 figure was 0.28%, 28.0% up from the prior year.
  • Return on Invested Capital was 0.29% for Q4 2025 at Day One Biopharmaceuticals, up from 0.38% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.25% in Q2 2025, with the low at 0.97% in Q2 2024.